Raymond James Trust N.A. Ionis Pharmaceuticals Inc Transaction History

Raymond James Trust N.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$41.6 - $63.4 $174,179 - $265,455	-4,187 Closed	0 $0
Q4 2019 Jan 14, 2020	SELL	$53.85 - $65.27 $61,927 - $75,060	-1,150 Reduced 21.55%	4,187 $253,000
Q3 2019 Oct 24, 2019	BUY	$59.06 - $72.15 $51,145 - $62,481	866 Added 19.37%	5,337 $320,000
Q2 2019 Jul 15, 2019	SELL	$62.09 - $86.14 $1,428 - $1,981	-23 Reduced 0.51%	4,471 $287,000
Q1 2019 Apr 15, 2019	SELL	$52.92 - $81.17 $47,575 - $72,971	-899 Reduced 16.67%	4,494 $365,000
Q4 2018 Jan 29, 2019	SELL	$43.37 - $59.54 $19,429 - $26,673	-448 Reduced 7.67%	5,393 $292,000
Q3 2018 Oct 16, 2018	BUY	$42.88 - $53.7 $943 - $1,181	22 Added 0.38%	5,841 $302,000
Q2 2018 Jul 11, 2018	SELL	$40.53 - $50.7 $5,431 - $6,793	-134 Reduced 2.25%	5,819 $243,000
Q1 2018 Apr 05, 2018	BUY	$44.08 - $55.05 $6,391 - $7,982	145 Added 2.5%	5,953 $263,000
Q4 2017 Feb 02, 2018	BUY	$50.3 - $64.39 $6,840 - $8,757	136 Added 2.4%	5,808 $292,000
Q3 2017 Oct 24, 2017	BUY	$45.56 - $59.57 $5,421 - $7,088	119 Added 2.14%	5,672 $287,000
Q2 2017 Aug 10, 2017	BUY	N/A	5,553	5,553 $282,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.